These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Relapsing fever Middelveen MJ; Shah JS; Fesler MC; Stricker RB Int J Gen Med; 2018; 11():373-382. PubMed ID: 30288084 [TBL] [Abstract][Full Text] [Related]
24. Whole genome sequencing and phylogenetic analysis of strains of the agent of Lyme disease Borrelia burgdorferi from Canadian emergence zones. Tyler S; Tyson S; Dibernardo A; Drebot M; Feil EJ; Graham M; Knox NC; Lindsay LR; Margos G; Mechai S; Van Domselaar G; Thorpe HA; Ogden NH Sci Rep; 2018 Jul; 8(1):10552. PubMed ID: 30002414 [TBL] [Abstract][Full Text] [Related]
25. Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada. Ogden NH; Arsenault J; Hatchette TF; Mechai S; Lindsay LR PLoS One; 2017; 12(2):e0171731. PubMed ID: 28182723 [TBL] [Abstract][Full Text] [Related]
26. Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Cook MJ; Puri BK Int J Gen Med; 2016; 9():427-440. PubMed ID: 27920571 [TBL] [Abstract][Full Text] [Related]
27. Similarities in murine infection and immune response to Borrelia bissettii and Borrelia burgdorferi sensu stricto. Leydet BF; Liang FT Microbiology (Reading); 2015 Dec; 161(12):2352-60. PubMed ID: 26419825 [TBL] [Abstract][Full Text] [Related]
28. Evolutionary aspects of emerging Lyme disease in Canada. Ogden NH; Feil EJ; Leighton PA; Lindsay LR; Margos G; Mechai S; Michel P; Moriarty TJ Appl Environ Microbiol; 2015 Nov; 81(21):7350-9. PubMed ID: 26296723 [TBL] [Abstract][Full Text] [Related]
29. Complex population structure of Borrelia burgdorferi in southeastern and south central Canada as revealed by phylogeographic analysis. Mechai S; Margos G; Feil EJ; Lindsay LR; Ogden NH Appl Environ Microbiol; 2015 Feb; 81(4):1309-18. PubMed ID: 25501480 [TBL] [Abstract][Full Text] [Related]
30. Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen. Halpern MD; Molins CR; Schriefer M; Jewett MW Clin Vaccine Immunol; 2014 Aug; 21(8):1094-105. PubMed ID: 24899074 [TBL] [Abstract][Full Text] [Related]
31. Lipoprotein succession in Borrelia burgdorferi: similar but distinct roles for OspC and VlsE at different stages of mammalian infection. Tilly K; Bestor A; Rosa PA Mol Microbiol; 2013 Jul; 89(2):216-27. PubMed ID: 23692497 [TBL] [Abstract][Full Text] [Related]
32. Evolving perspectives on lyme borreliosis in Canada. Sperling J; Middelveen M; Klein D; Sperling F Open Neurol J; 2012; 6():94-103. PubMed ID: 23091570 [TBL] [Abstract][Full Text] [Related]
33. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Wormser GP; Schriefer M; Aguero-Rosenfeld ME; Levin A; Steere AC; Nadelman RB; Nowakowski J; Marques A; Johnson BJ; Dumler JS Diagn Microbiol Infect Dis; 2013 Jan; 75(1):9-15. PubMed ID: 23062467 [TBL] [Abstract][Full Text] [Related]
34. Investigation of genotypes of Borrelia burgdorferi in Ixodes scapularis ticks collected during surveillance in Canada. Ogden NH; Margos G; Aanensen DM; Drebot MA; Feil EJ; Hanincová K; Schwartz I; Tyler S; Lindsay LR Appl Environ Microbiol; 2011 May; 77(10):3244-54. PubMed ID: 21421790 [TBL] [Abstract][Full Text] [Related]
37. Population structure of the lyme borreliosis spirochete Borrelia burgdorferi in the western black-legged tick (Ixodes pacificus) in Northern California. Girard YA; Travinsky B; Schotthoefer A; Fedorova N; Eisen RJ; Eisen L; Barbour AG; Lane RS Appl Environ Microbiol; 2009 Nov; 75(22):7243-52. PubMed ID: 19783741 [TBL] [Abstract][Full Text] [Related]
38. Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice. Krupka I; Knauer J; Lorentzen L; O'Connor TP; Saucier J; Straubinger RK Clin Vaccine Immunol; 2009 Nov; 16(11):1546-62. PubMed ID: 19726618 [TBL] [Abstract][Full Text] [Related]
39. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Wormser GP; Nowakowski J; Nadelman RB; Visintainer P; Levin A; Aguero-Rosenfeld ME Clin Vaccine Immunol; 2008 Oct; 15(10):1519-22. PubMed ID: 18716009 [TBL] [Abstract][Full Text] [Related]
40. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Wormser GP; Liveris D; Hanincová K; Brisson D; Ludin S; Stracuzzi VJ; Embers ME; Philipp MT; Levin A; Aguero-Rosenfeld M; Schwartz I Clin Infect Dis; 2008 Oct; 47(7):910-4. PubMed ID: 18724824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]